Literature DB >> 4674909

Oxidation of 2-phenylethylhydrazine by monoamine oxidase.

K F Tipton, I P Spires.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4674909     DOI： 10.1016/0006-2952(72)90278-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

Review 1.  Neurochemical and metabolic aspects of antidepressants: an overview.

Authors:  G B Baker; R T Coutts; A J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  The myth of phenelzine acetylation.

Authors:  E F Marshall
Journal:  Br Med J       Date:  1976-10-02

3.  The reaction pathway of membrane-bound rat liver mitochondrial monoamine oxidase.

Authors:  M D Houslay; K F Tipton
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

4.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

5.  Inhibition of monoamine oxidase by substituted hydrazines.

Authors:  K F Tipton
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

6.  Purification and properties of the trimethylamine dehydrogenase of bacterium 4B6.

Authors:  J Colby; L J Zatman
Journal:  Biochem J       Date:  1974-12       Impact factor: 3.857

7.  Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzine.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

Review 8.  Metabolism of monoamine oxidase inhibitors.

Authors:  G B Baker; L J Urichuk; K F McKenna; S H Kennedy
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

9.  Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.

Authors:  Dmitriy Matveychuk; Emerson Nunes; Nasir Ullah; Carlos A Velázquez-Martinez; Erin M MacKenzie; Glen B Baker
Journal:  J Neural Transm (Vienna)       Date:  2013-02-08       Impact factor: 3.575

Review 10.  Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.

Authors:  Dmitriy Matveychuk; Erin M MacKenzie; David Kumpula; Mee-Sook Song; Andrew Holt; Satyabrata Kar; Kathryn G Todd; Paul L Wood; Glen B Baker
Journal:  Cell Mol Neurobiol       Date:  2021-04-10       Impact factor: 5.046
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.